Why GAN Stock Is Trading Higher Today
GAN Ltd (NASDAQ: GAN) is trading significantly higher Thursday morning after the company announced preliminary second-quarter results.
Helen Of Troy Q1 Results Beat Estimates; Provides Downbeat Outlook For FY22
Helen of Troy Limited (NASDAQ:HELE) reported first-quarter FY22 sales of $541.2 million, a 28.6% growth year-on-year, beating the…
Nephros Sees 40% Increase In Q2 Sales, Submits HDF Product For FDA Approval
Nephros Inc (NASDAQ:NEPH) has announced preliminary results and expects Q2 sales of approximately $2.2 million, representing a Y/Y increase of…
Stellantis Targets Electric Vehicles With $35.5B Plan: What Investors Need To Know
Stellantis NV (NYSE: STLA) on Thursday announced an aggressive plan to gain ground in the global electric vehicle market, saying it will spend 30 billion euros ($35.5 billion) by 2025 to add EVs with between 300 miles and 500 miles of range.
Digital Brands Group Estimates Q1 Revenues Increased 100% QoQ
Digital Brands Group, Inc. (the "Company" or "DBG") (NASDAQ:DBGI), a curated collection of luxury lifestyle, digital-first brands, announced that its initial estimate of financial
Why Tessco Shares Are Skyrocketing Today
TESSCO Technologies, Inc. (NASDAQ: TESS) shares are trading higher by 26% at $7.26 Thursday morning after the company issued first-quarter sales guidance above estimates.
Silicon Motion Sees Prelim. Q2 Revenue Growth ~20%, Above Original 5%-10% Range
Silicon Motion Technology Corporation (NASDAQ:SIMO) ("Silicon Motion" or the "Company"), a global leader in NAND flash controllers for solid state storage devices, announces that based on its
Safe-T Group Sees Sales Of $1.62M-$1.78M For The Quarter Ended Jun. 30, Up 50%-65% YoY
Safe-T® Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions and intelligent data collection, today provided an estimated revenue range for the three- and six-month periods ended June 30,
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 6)
Hollysys Sees FY21 Revs $560M-$595M Vs $547.8M Est
Outlook
"The Company provides an update on its financial outlook for the year ended June 30, 2021 ("FY2021"), an update from the outlook provided on August 13,